FSGS Recurrence Collaboration: Report of a Symposium.
作者信息
Gipson Debbie S, Wang Chia-Shi, Salmon Eloise, Gbadegesin Rasheed, Naik Abhijit, Sanna-Cherchi Simone, Fornoni Alessia, Kretzler Matthias, Merscher Sandra, Hoover Paul, Kidwell Kelley, Saleem Moin, Riella Leonardo, Holzman Lawrence, Jackson Annette, Olabisi Opeyemi, Cravedi Paolo, Freedman Benjamin Solomon, Himmelfarb Jonathan, Vivarelli Marina, Harder Jennifer, Klein Jon, Burke George, Rheault Michelle, Spino Cathie, Desmond Hailey E, Trachtman Howard
机构信息
Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
Department of Pediatrics, Emory University, Atlanta, GA, USA.
出版信息
Glomerular Dis. 2023 Nov 14;4(1):1-10. doi: 10.1159/000535138. eCollection 2024 Jan-Dec.
Abstract
摘要
相似文献
1
FSGS Recurrence Collaboration: Report of a Symposium.局灶节段性肾小球硬化复发协作组：研讨会报告
Glomerular Dis. 2023 Nov 14;4(1):1-10. doi: 10.1159/000535138. eCollection 2024 Jan-Dec.
2
Cyclophosphamide as a Treatment for Focal Segmental Glomerular Sclerosis Recurrence in a Kidney Transplant Patient.环磷酰胺治疗肾移植患者局灶节段性肾小球硬化复发。
Am J Case Rep. 2021 Feb 4;22:e929097. doi: 10.12659/AJCR.929097.
3
Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience.42例儿童同种异体移植肾复发性局灶节段性肾小球硬化的发病率、治疗及预后——单中心经验
Transplantation. 1991 Feb;51(2):401-5. doi: 10.1097/00007890-199102000-00025.
4
Focal Segmental Glomerulosclerosis and Recurrence in Living Donor Recipients.局灶节段性肾小球硬化症与活体供肾受者中的复发
Res Rep Urol. 2021 Jul 14;13:495-499. doi: 10.2147/RRU.S308994. eCollection 2021.
5
Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft.对既往肾移植复发的患者进行局灶节段性肾小球硬化复发的预防性治疗。
Nephrol Dial Transplant. 2025 Feb 28;40(3):475-483. doi: 10.1093/ndt/gfae108.
6
Therapeutic Options for Recurrence of Primary Focal Segmental Glomerulonephritis (FSGS) in the Renal Allograft: Single-Center Experience.肾移植中原发性局灶节段性肾小球硬化症（FSGS）复发的治疗选择：单中心经验
J Clin Med. 2021 Jan 20;10(3):373. doi: 10.3390/jcm10030373.
7
Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis.因局灶节段性肾小球硬化症接受再次移植的患者疾病复发情况。
Transplantation. 1992 Apr;53(4):755-7. doi: 10.1097/00007890-199204000-00009.
8
Recurrence of FSGS after Kidney Transplantation in Adults.成人肾移植后 FSGS 的复发。
Clin J Am Soc Nephrol. 2020 Feb 7;15(2):247-256. doi: 10.2215/CJN.08970719. Epub 2020 Jan 23.
9
Focal segmental glomerulosclerosis and renal transplantation.局灶节段性肾小球硬化症与肾移植
Transplant Proc. 2007 Apr;39(3):737-43. doi: 10.1016/j.transproceed.2007.02.010.
10
Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.原发性局灶节段性肾小球硬化的肾移植：结局及对复发的治疗反应
Transplantation. 2009 Apr 27;87(8):1232-9. doi: 10.1097/TP.0b013e31819f12be.
引用本文的文献
1
RESOLVE: Recurrence Posttransplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease.RESOLVE：局灶节段性肾小球硬化症和微小病变病移植后复发观察性研究
Glomerular Dis. 2024 Dec 2;5(1):60-67. doi: 10.1159/000542839. eCollection 2025 Jan-Dec.
2
Natural History and Clinicopathological Associations of TRPC6-Associated Podocytopathy.与TRPC6相关的足细胞病的自然史及临床病理关联
J Am Soc Nephrol. 2025 Feb 1;36(2):274-289. doi: 10.1681/ASN.0000000501. Epub 2024 Oct 1.
3
Transplantation: platform to study recurrence of disease.移植：研究疾病复发的平台。
Front Immunol. 2024 Mar 1;15:1354101. doi: 10.3389/fimmu.2024.1354101. eCollection 2024.
本文引用的文献
1
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis.精准肾脏医学发现微小病变性肾病和局灶节段性肾小球硬化症中肿瘤坏死因子激活的可变性。
Kidney Int. 2023 Mar;103(3):565-579. doi: 10.1016/j.kint.2022.10.023. Epub 2022 Nov 25.
2
Activation of Stimulator of IFN Genes (STING) Causes Proteinuria and Contributes to Glomerular Diseases.干扰素基因刺激物（STING）的激活会导致蛋白尿，并有助于肾小球疾病。
J Am Soc Nephrol. 2022 Dec;33(12):2153-2173. doi: 10.1681/ASN.2021101286. Epub 2022 Oct 5.
3
Long-term Apheresis in the Management of Patients With Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation.长期血液分离术在肾移植后复发性局灶节段性肾小球硬化患者管理中的应用
Kidney Int Rep. 2022 Mar 11;7(6):1424-1427. doi: 10.1016/j.ekir.2022.03.002. eCollection 2022 Jun.
4
Focal segmental glomerulosclerosis: Risk for recurrence and interventions to optimize outcomes following recurrence.局灶节段性肾小球硬化：复发风险和复发后优化结局的干预措施。
Pediatr Transplant. 2022 Sep;26(6):e14307. doi: 10.1111/petr.14307. Epub 2022 May 19.
5
Glomerular endothelial cell-podocyte stresses and crosstalk in structurally normal kidney transplants.结构正常的移植肾中肾小球内皮细胞-足细胞的应激和串扰。
Kidney Int. 2022 Apr;101(4):779-792. doi: 10.1016/j.kint.2021.11.031. Epub 2021 Dec 22.
6
Comprehensive phenotyping of human peripheral blood B lymphocytes in pathological conditions.在病理条件下对人外周血 B 淋巴细胞进行全面表型分析。
Cytometry A. 2022 Feb;101(2):140-149. doi: 10.1002/cyto.a.24518. Epub 2021 Dec 1.
7
Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations.肾类器官和临床人群中 SARS-CoV-2 反应的交叉验证。
JCI Insight. 2021 Dec 22;6(24):e154882. doi: 10.1172/jci.insight.154882.
8
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology.在微小病变性肾病中发现针对 Nephrin 的自身抗体支持新的自身免疫病因。
J Am Soc Nephrol. 2022 Jan;33(1):238-252. doi: 10.1681/ASN.2021060794. Epub 2021 Nov 3.
9
CyTOF-Enabled Analysis Identifies Class-Switched B Cells as the Main Lymphocyte Subset Associated With Disease Relapse in Children With Idiopathic Nephrotic Syndrome.基于液质联用技术的分析鉴定出，在特发性肾病综合征患儿中，与疾病复发相关的主要淋巴细胞亚群是类别转换 B 细胞。
Front Immunol. 2021 Sep 21;12:726428. doi: 10.3389/fimmu.2021.726428. eCollection 2021.
10
Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes.受者载脂蛋白 L1 风险等位基因与死亡相关的肾移植存活率和排斥反应有关。
J Clin Invest. 2021 Nov 15;131(22). doi: 10.1172/JCI146643.
Zotero 插件